Next Article in Journal
Iodine Intake and Risk of Mortality: Evidence from a Nationally Representative Korean Cohort
Previous Article in Journal
Intervention Using Low-Na/K Seasonings and Dairy at Japanese Company Cafeterias as a Practical Approach to Decrease Dietary Na/K and Prevent Hypertension
Previous Article in Special Issue
Betulinic Acid Reduces Intestinal Inflammation and Enhances Intestinal Tight Junctions by Modulating the PPAR-γ/NF-κB Signaling Pathway in Intestinal Cells and Organoids
 
 
Systematic Review
Peer-Review Record

Efficacy and Safety of Placental Extract on Menopausal Symptoms: A Systematic Review

Nutrients 2025, 17(24), 3857; https://doi.org/10.3390/nu17243857
by Sára Papp 1, László Tűű 2,3, Katalin Nas 3, Zsófia Telkes 1,2, Lotti Keszthelyi 1, Márton Keszthelyi 1, Nándor Ács 1,*, Szabolcs Várbíró 1,4 and Marianna Török 1,*
Reviewer 1: Anonymous
Reviewer 2:
Reviewer 3: Anonymous
Nutrients 2025, 17(24), 3857; https://doi.org/10.3390/nu17243857
Submission received: 19 November 2025 / Revised: 4 December 2025 / Accepted: 8 December 2025 / Published: 10 December 2025
(This article belongs to the Special Issue Exploring the Role of Bioactive Compounds in Immunonutrition)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

Esteemed authors and editorial team,

This systematic review addressing the issues of alternative therapies for alleviating the symptoms of menopause is welcome in the context of this topic which is always of interest and has been the subject of important changes of perspective.

The article is well written, I especially like the fact that the authors underline the short timeframe of treatment administration and the impossibility to generalize results, since these products have only been used in Asian countries.

 

I suggest the authors should comment more extensively than “Unlike conventional hormone therapy, which is associated with increased cardiovascular risks, 356 placental extracts showed no adverse cardiovascular effects” at line 355.

 

It is quite clear that extended use of systemic HT should not be confused with age at the initiation of systemic HT (>60 years of or >10 years after menopause onset), which was shown to be the modulating factor between a protective versus aggressive factor for CHD risk.

 

There are several English language faults, please carefully reread the article, I will only mention

Line 362 – aboutan

Line 368 - for having weighting

Author Response

Attached file. 

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

Dear authors,

The manuscript “Effects of Placental Extract on Menopausal Symptoms: a Systematic Review” addresses a highly relevant and clinically significant topic: the efficacy and safety of placental extract for menopausal symptoms. 

However, several areas require clarification, reconciliation, and minor grammatical corrections to elevate the manuscript to a high standard for publication. 

Please read the following file for details.

Respectfully 

The Reviewer

Comments for author File: Comments.pdf

Author Response

Attached file. 

Author Response File: Author Response.pdf

Reviewer 3 Report

Comments and Suggestions for Authors

paper title - Effects of Placental Extract on Menopausal Symptoms: a Systematic Review

here are some comments - suggestions, and questions

abstract is concise and clear, paper follow PRISMA guidelines, searched PubMed, Embase, and Scopus (2004–2024), and focused on RCTs using porcine or human placenta extracts - why 2004 to 2024 - this should be noted

a timely study with the first systematic review on placental extracts with solid method noted on PROSPERO and used PICO clearly

some issue to consider

- as i read, most studies are within an Asian context - which might limit global applicability – symptoms vary by race/ethnicity, while also the follow up seems short (up to 24 weeks)

long term safety or effects might not be explored

also some outcome/result gap might be noted - many focus on socres and physical symptoms is good, but secondary ones such as psych, aesthetics -  get less detail - clarification might be needed

RoB assessment shows "some concerns" in areas like adherence (63.6% low), but supplemental figures aren't described much -  would suggest to further elaborate and maybe provide or include a summary table of RoB per domain (this would clear things up)

 

 

 

 

Author Response

Attached file. 

Author Response File: Author Response.pdf

Back to TopTop